mvx10 macroview dissecting scope (Olympus)
96
Structured Review
Olympus
mvx10 macroview dissecting scope
Mvx10 Macroview Dissecting Scope, supplied by Olympus, used in various techniques. Bioz Stars score: 96/100, based on 2347 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mvx10+macroview+dissecting+scope/MVX10+Macro+Zoom+Fluorescence+Microscope+System/10__7150_slash_thno__112649-159-8-15
Average 96 stars, based on 2347 article reviews
Mvx10 Macroview Dissecting Scope, supplied by Olympus, used in various techniques. Bioz Stars score: 96/100, based on 2347 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mvx10+macroview+dissecting+scope/MVX10+Macro+Zoom+Fluorescence+Microscope+System/10__7150_slash_thno__112649-159-8-15
Average 96 stars, based on 2347 article reviews
mvx10 macroview dissecting scope - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Staining:Article Title: Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways Article Snippet: .. Stained slides were mounted and imaged using an Article Title: Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways Article Snippet: .. Stained slides were mounted and imaged using an Article Title: Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Article Snippet: For antibody staining, consecutive sections were incubated with primary antibodies against CD68 (1:500 dilution; Abcam, MA, USA), HIF1α (1:800 dilution; Abcam), vWF (1:20 dilution; Abcam), or fibronectin (1:200 dilution; Abcam). .. All stained cross-sections were digitally imaged with an Article Title: Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy Article Snippet: .. After retrieval of antigen using DAKO target retrieval solution at 95–99 °C for 40 min, followed by washing, the slides were blocked with peroxidase blocking buffer (DAKO Company) for 5 min. After washing buffer (DAKO Company), the slides were incubated with KIF11 rabbit antibody diluted in DAKO antibody solution for 1 h. The slides were then washed and incubated with peroxidase-labeled polymer for 30 min. After washing and staining with DAB+ substrate–chromogen solution and hematoxylin, the slides that remounted and viewed under a Article Title: Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery Article Snippet: For antibody staining, consecutive sections were incubated with primary antibodies against CD68 (1:500 dilution; Abcam, MA, USA), HIF1α (1:800 dilution; Abcam), vWF (1:20 dilution; Abcam), or fibronectin (1:200 dilution; Abcam). .. All stained cross-sections were digitally imaged with an Microscopy:Article Title: Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Article Snippet: For antibody staining, consecutive sections were incubated with primary antibodies against CD68 (1:500 dilution; Abcam, MA, USA), HIF1α (1:800 dilution; Abcam), vWF (1:20 dilution; Abcam), or fibronectin (1:200 dilution; Abcam). .. All stained cross-sections were digitally imaged with an Article Title: Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery Article Snippet: For antibody staining, consecutive sections were incubated with primary antibodies against CD68 (1:500 dilution; Abcam, MA, USA), HIF1α (1:800 dilution; Abcam), vWF (1:20 dilution; Abcam), or fibronectin (1:200 dilution; Abcam). .. All stained cross-sections were digitally imaged with an Blocking Assay:Article Title: Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy Article Snippet: .. After retrieval of antigen using DAKO target retrieval solution at 95–99 °C for 40 min, followed by washing, the slides were blocked with peroxidase blocking buffer (DAKO Company) for 5 min. After washing buffer (DAKO Company), the slides were incubated with KIF11 rabbit antibody diluted in DAKO antibody solution for 1 h. The slides were then washed and incubated with peroxidase-labeled polymer for 30 min. After washing and staining with DAB+ substrate–chromogen solution and hematoxylin, the slides that remounted and viewed under a Incubation:Article Title: Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy Article Snippet: .. After retrieval of antigen using DAKO target retrieval solution at 95–99 °C for 40 min, followed by washing, the slides were blocked with peroxidase blocking buffer (DAKO Company) for 5 min. After washing buffer (DAKO Company), the slides were incubated with KIF11 rabbit antibody diluted in DAKO antibody solution for 1 h. The slides were then washed and incubated with peroxidase-labeled polymer for 30 min. After washing and staining with DAB+ substrate–chromogen solution and hematoxylin, the slides that remounted and viewed under a Polymer:Article Title: Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy Article Snippet: .. After retrieval of antigen using DAKO target retrieval solution at 95–99 °C for 40 min, followed by washing, the slides were blocked with peroxidase blocking buffer (DAKO Company) for 5 min. After washing buffer (DAKO Company), the slides were incubated with KIF11 rabbit antibody diluted in DAKO antibody solution for 1 h. The slides were then washed and incubated with peroxidase-labeled polymer for 30 min. After washing and staining with DAB+ substrate–chromogen solution and hematoxylin, the slides that remounted and viewed under a |